Bristol-Myers Squibb Named Top 10 Company for Diversity & Inclusion

In the 2018 Thomson Reuters’ Diversity & Inclusion Index

Sep 13, 2018 11:45 AM ET

We’re honored to be in the top 10 of Thomson Reuters’ 2018 Diversity & Inclusion (D&I) Index. Global Diversity & Inclusion is a key priority for our company and we are committed to creating a culture that empowers our people to share their unique perspectives and pursue innovative ideas to bring transformational medicines to patients.

Continue reading about Bristol-Myers Squibb's commitment to Global D&I.

Bristol-Myers Squibb Named Top 10 Company for Diversity & Inclusion

In the 2018 Thomson Reuters’ Diversity & Inclusion Index

More from Bristol Myers Squibb Company

Building a Better Future: Bristol Myers Squibb 2023 ESG Report

Bristol Myers Squibb Releases 2023 ESG Report Demonstrating Progress and Setting New Long-Term Goals

Bristol Myers Squibb Releases 2023 Environmental, Social and Governance Report Demonstrating Progress and Setting New Long-Term Goals

Bristol Myers Squibb Expands Health Equity Grant Initiatives to Improve Health Outcomes

Bristol Myers Squibb Named One of America’s Most JUST Companies by JUST Capital and CNBC

How Is BMS Making Progress on Its Renewable Energy Goals?

Basketball Legend Kareem Abdul-Jabbar Joins No Time to Wait Campaign to Raise Awareness of Atrial Fibrillation (AFib) and its Symptoms

Reflecting on Research in Genitourinary Cancers